{"abstract": "Sanofi intends to add a few dollars a share to its $69-a-share offer, and will likely allow for additional payments to Genzyme shareholders if one of the company\u2019s drugs hits certain sales expectations.", "web_url": "https://dealbook.nytimes.com/2011/02/01/sanofi-plans-to-raise-genzyme-bid/", "snippet": "Sanofi intends to add a few dollars a share to its $69-a-share offer, and will likely allow for additional payments to Genzyme shareholders if one of the company\u2019s drugs hits certain sales expectations.", "lead_paragraph": "Sanofi-Aventis plans to raise its takeover bid for Genzyme by several dollars a share, in an effort to clinch a deal for the biopharmaceutical company, people briefed on the matter told DealBook on Tuesday.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Plans to Raise Genzyme Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis S.A", "rank": 2, "major": "N"}], "pub_date": "2011-02-01T19:38:27+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/aa94d313-0b05-5936-b4ef-ba2034646621", "word_count": 263, "uri": "nyt://article/aa94d313-0b05-5936-b4ef-ba2034646621"}